Shortened derivatives from native antimicrobial peptide LyeTx I: In vitro and in vivo biological activity assessment.
Leonardo Lima FuscaldiJoaquim Teixeira de Avelar JúniorDaniel Moreira Dos SantosDaiane BoffVivian Louise Soares de OliveiraKarla Aparecida Guimarães Gusmão GomesRosana de Carvalho CruzPatrícia Luciana de OliveiraPaula Prazeres MagalhãesPatricia Silva CisalpinoLuiz de Macêdo FariasElaine Maria de Souza-FagundesJohannes DelpMarcel LeistJarbas Magalhães ResendeFlávio Almeida AmaralAdriano Monteiro de Castro PimentaSimone Odília Antunes FernandesValbert Nascimento CardosoMaria Elena de LimaPublished in: Experimental biology and medicine (Maywood, N.J.) (2020)
In the continuing search for novel antibiotics, antimicrobial peptides are promising molecules, due to different mechanisms of action compared to classic antibiotics and to their selectivity for interaction with microorganism cells rather than with mammalian cells. Previously, our research group has isolated the antimicrobial peptide LyeTx I from the venom of the spider Lycosa erythrognatha. Here, we proposed to synthesize three novel shortened derivatives from LyeTx I (LyeTx I mn; LyeTx I mnΔK; LyeTx I mnΔKAc) and to evaluate their toxicity and biological activity as potential antimicrobial agents. Peptides were synthetized by Fmoc strategy and circular dichroism analysis was performed, showing that the three novel shortened derivatives may present membranolytic activity, like the original LyeTx I, once they folded as an alpha helix in 2.2.2-trifluorethanol and sodium dodecyl sulfate. In vitro assays revealed that the shortened derivative LyeTx I mnΔK presents the best score between antimicrobial (↓ MIC) and hemolytic (↑ EC50) activities among the synthetized shortened derivatives, and LUHMES cell-based NeuriTox test showed that it is less neurotoxic than the original LyeTx I (EC50 [LyeTx I mnΔK] ⋙ EC50 [LyeTx I]). In vivo data, obtained in a mouse model of septic arthritis induced by Staphylococcus aureus, showed that LyeTx I mnΔK is able to reduce infection, as demonstrated by bacterial recovery assay (∼10-fold reduction) and scintigraphic imaging (less technetium-99m labeled-Ceftizoxime uptake by infectious site). Infection reduction led to inflammatory process and pain decreases, as shown by immune cells recruitment reduction and threshold nociception increment, when compared to positive control group. Therefore, among the three shortened peptide derivatives, LyeTx I mnΔK is the best candidate as antimicrobial agent, due to its smaller amino acid sequence and toxicity, and its greater biological activity.
Keyphrases
- staphylococcus aureus
- room temperature
- transition metal
- metal organic framework
- amino acid
- mouse model
- oxidative stress
- structure activity relationship
- single cell
- rheumatoid arthritis
- high throughput
- chronic pain
- pain management
- high resolution
- acute kidney injury
- cell therapy
- cystic fibrosis
- biofilm formation
- electronic health record
- transcription factor
- pet imaging
- bone marrow
- cell death
- methicillin resistant staphylococcus aureus
- dna binding
- big data
- deep learning
- spinal cord
- clinical evaluation